Global Obesity Intervention Devices Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Clinics & Others), By Device (Gastric Bands, Gastric Balloon and Gastric Stimulation System), By Regional Outlook and Forecast, 2023 - 202

Global Obesity Intervention Devices Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Clinics & Others), By Device (Gastric Bands, Gastric Balloon and Gastric Stimulation System), By Regional Outlook and Forecast, 2023 - 2029


The Global Obesity Intervention Devices Market size is expected to reach $352 Million by 2029, rising at a market growth of 5.3% CAGR during the forecast period.

Hospitals are increasingly adopting advanced and innovative devices and have expert professionals for performing procedures and managing patients' weight loss journeys. Thus, Hospitals are expected to generate approximately 3/4th share of the market revenue by 2029. According to WHO, 38.2 million children under the age of five were overweight or obese in 2019. Overweight and obesity, once thought to be an issue only in high-income nations, are increasingly becoming more prevalent in low- and middle-income nations, especially in metropolitan areas. Since 2000, there has been a nearly 24% increase in the proportion of overweight children under 5 overweight children in Africa. In 2019, Asia was home to over half of the world's young overweight or obese children. Some of the factors impacting the market are Growing rate of obesity worldwide, Growing investment in healthcare sector and High cost of production and limited funds.

Overweight or obesity are terms used in the business sector to describe the state of having unhealthy body fat that may be harmful to one's health. Overweight is defined as having a body mass index (BMI) of 25 or higher, and obesity as having a BMI of 30 or higher. As a result, there is a growing market due to increased obesity and overweight people. Growing numbers and sizes of investments by governments of various nations in the healthcare sector are one of the primary drivers of the market’s growth. However, the high cost of research & development of obesity intervention devices and the absence of financial help may limit the market growth for obesity surgery devices.

Due to the global pandemic, numerous hospitals have had to close their doors or restrict their services to only emergency care. As a result, elective procedures such as gastric banding and implantation of gastric balloons have had to be delayed or abandoned. In addition, the fear of getting infected has also discouraged patients from seeking medical attention for such issues, further decreasing the need for obesity intervention services. However, the market witnessed an upsurge in demand again after the uplifting of restrictions imposed to curb the effects of COVID-19.

Device Outlook

Based on device, the market is segmented into gastric bands, gastric balloon, and gastric stimulation system. In 2022, the gastric balloon segment covered a considerable held the highest revenue share in the market. One to three silicon balloons are inserted into the patient's stomach during a gastric balloon treatment, also known as an endoscopic intragastric balloon, over a few months to help the patient lose about 30% of their extra weight and therefore improve their health.

End User Outlook

By end user, the market is bifurcated into hospitals and clinics. In 2022, the hospital segment witnessed the largest revenue share in the market. The number of people seeking medical attention for obesity is increasing, resulting in a rise in revenue for this market segment. In order to provide comprehensive obesity treatment, hospitals also have the necessary assets and infrastructure, including specialized medical equipment and highly trained medical professionals. This element is anticipated to support the market’s expansion in this segment.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region dominated the market with the maximum revenue share. This is because a large population suffers from chronic diseases, a growing demand for minimally invasive surgery procedures, and the healthcare industry is becoming increasingly important. As a result, there is a sharp rise in the demand for gastric bands in this region, supporting the market expansion.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Johnson & Johnson, Apollo Endosurgery, Inc. (Boston Scientific Corporation), ReShape Lifesciences, Inc., AbbVie, Inc., Allurion Technologies, Inc., Spatz FGIA, Inc, Cousin Surgery, A.M.I. GmbH, ENDALIS, and GI Dynamics, Inc.

Scope of the Study

Market Segments covered in the Report:

By End User
  • Hospitals
  • Clinics & Others
By Device
  • Gastric Bands
  • Gastric Balloon
  • Gastric Stimulation System
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Johnson & Johnson
  • Apollo Endosurgery, Inc. (Boston Scientific Corporation)
  • ReShape Lifesciences, Inc.
  • AbbVie, Inc.
  • Allurion Technologies, Inc.
  • Spatz FGIA, Inc
  • Cousin Surgery
  • A.M.I. GmbH
  • ENDALIS
  • GI Dynamics, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Obesity Intervention Devices Market, by End User
1.4.2 Global Obesity Intervention Devices Market, by Device
1.4.3 Global Obesity Intervention Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Obesity Intervention Devices Market by End User
3.1 Global Hospitals Market by Region
3.2 Global Clinics & Others Market by Region
Chapter 4. Global Obesity Intervention Devices Market by Device
4.1 Global Gastric Bands Market by Region
4.2 Global Gastric Balloon Market by Region
4.3 Global Gastric Stimulation System Market by Region
Chapter 5. Global Obesity Intervention Devices Market by Region
5.1 North America Obesity Intervention Devices Market
5.1.1 North America Obesity Intervention Devices Market by End User
5.1.1.1 North America Hospitals Market by Country
5.1.1.2 North America Clinics & Others Market by Country
5.1.2 North America Obesity Intervention Devices Market by Device
5.1.2.1 North America Gastric Bands Market by Country
5.1.2.2 North America Gastric Balloon Market by Country
5.1.2.3 North America Gastric Stimulation System Market by Country
5.1.3 North America Obesity Intervention Devices Market by Country
5.1.3.1 US Obesity Intervention Devices Market
5.1.3.1.1 US Obesity Intervention Devices Market by End User
5.1.3.1.2 US Obesity Intervention Devices Market by Device
5.1.3.2 Canada Obesity Intervention Devices Market
5.1.3.2.1 Canada Obesity Intervention Devices Market by End User
5.1.3.2.2 Canada Obesity Intervention Devices Market by Device
5.1.3.3 Mexico Obesity Intervention Devices Market
5.1.3.3.1 Mexico Obesity Intervention Devices Market by End User
5.1.3.3.2 Mexico Obesity Intervention Devices Market by Device
5.1.3.4 Rest of North America Obesity Intervention Devices Market
5.1.3.4.1 Rest of North America Obesity Intervention Devices Market by End User
5.1.3.4.2 Rest of North America Obesity Intervention Devices Market by Device
5.2 Europe Obesity Intervention Devices Market
5.2.1 Europe Obesity Intervention Devices Market by End User
5.2.1.1 Europe Hospitals Market by Country
5.2.1.2 Europe Clinics & Others Market by Country
5.2.2 Europe Obesity Intervention Devices Market by Device
5.2.2.1 Europe Gastric Bands Market by Country
5.2.2.2 Europe Gastric Balloon Market by Country
5.2.2.3 Europe Gastric Stimulation System Market by Country
5.2.3 Europe Obesity Intervention Devices Market by Country
5.2.3.1 Germany Obesity Intervention Devices Market
5.2.3.1.1 Germany Obesity Intervention Devices Market by End User
5.2.3.1.2 Germany Obesity Intervention Devices Market by Device
5.2.3.2 UK Obesity Intervention Devices Market
5.2.3.2.1 UK Obesity Intervention Devices Market by End User
5.2.3.2.2 UK Obesity Intervention Devices Market by Device
5.2.3.3 France Obesity Intervention Devices Market
5.2.3.3.1 France Obesity Intervention Devices Market by End User
5.2.3.3.2 France Obesity Intervention Devices Market by Device
5.2.3.4 Russia Obesity Intervention Devices Market
5.2.3.4.1 Russia Obesity Intervention Devices Market by End User
5.2.3.4.2 Russia Obesity Intervention Devices Market by Device
5.2.3.5 Spain Obesity Intervention Devices Market
5.2.3.5.1 Spain Obesity Intervention Devices Market by End User
5.2.3.5.2 Spain Obesity Intervention Devices Market by Device
5.2.3.6 Italy Obesity Intervention Devices Market
5.2.3.6.1 Italy Obesity Intervention Devices Market by End User
5.2.3.6.2 Italy Obesity Intervention Devices Market by Device
5.2.3.7 Rest of Europe Obesity Intervention Devices Market
5.2.3.7.1 Rest of Europe Obesity Intervention Devices Market by End User
5.2.3.7.2 Rest of Europe Obesity Intervention Devices Market by Device
5.3 Asia Pacific Obesity Intervention Devices Market
5.3.1 Asia Pacific Obesity Intervention Devices Market by End User
5.3.1.1 Asia Pacific Hospitals Market by Country
5.3.1.2 Asia Pacific Clinics & Others Market by Country
5.3.2 Asia Pacific Obesity Intervention Devices Market by Device
5.3.2.1 Asia Pacific Gastric Bands Market by Country
5.3.2.2 Asia Pacific Gastric Balloon Market by Country
5.3.2.3 Asia Pacific Gastric Stimulation System Market by Country
5.3.3 Asia Pacific Obesity Intervention Devices Market by Country
5.3.3.1 China Obesity Intervention Devices Market
5.3.3.1.1 China Obesity Intervention Devices Market by End User
5.3.3.1.2 China Obesity Intervention Devices Market by Device
5.3.3.2 Japan Obesity Intervention Devices Market
5.3.3.2.1 Japan Obesity Intervention Devices Market by End User
5.3.3.2.2 Japan Obesity Intervention Devices Market by Device
5.3.3.3 India Obesity Intervention Devices Market
5.3.3.3.1 India Obesity Intervention Devices Market by End User
5.3.3.3.2 India Obesity Intervention Devices Market by Device
5.3.3.4 South Korea Obesity Intervention Devices Market
5.3.3.4.1 South Korea Obesity Intervention Devices Market by End User
5.3.3.4.2 South Korea Obesity Intervention Devices Market by Device
5.3.3.5 Singapore Obesity Intervention Devices Market
5.3.3.5.1 Singapore Obesity Intervention Devices Market by End User
5.3.3.5.2 Singapore Obesity Intervention Devices Market by Device
5.3.3.6 Malaysia Obesity Intervention Devices Market
5.3.3.6.1 Malaysia Obesity Intervention Devices Market by End User
5.3.3.6.2 Malaysia Obesity Intervention Devices Market by Device
5.3.3.7 Rest of Asia Pacific Obesity Intervention Devices Market
5.3.3.7.1 Rest of Asia Pacific Obesity Intervention Devices Market by End User
5.3.3.7.2 Rest of Asia Pacific Obesity Intervention Devices Market by Device
5.4 LAMEA Obesity Intervention Devices Market
5.4.1 LAMEA Obesity Intervention Devices Market by End User
5.4.1.1 LAMEA Hospitals Market by Country
5.4.1.2 LAMEA Clinics & Others Market by Country
5.4.2 LAMEA Obesity Intervention Devices Market by Device
5.4.2.1 LAMEA Gastric Bands Market by Country
5.4.2.2 LAMEA Gastric Balloon Market by Country
5.4.2.3 LAMEA Gastric Stimulation System Market by Country
5.4.3 LAMEA Obesity Intervention Devices Market by Country
5.4.3.1 Brazil Obesity Intervention Devices Market
5.4.3.1.1 Brazil Obesity Intervention Devices Market by End User
5.4.3.1.2 Brazil Obesity Intervention Devices Market by Device
5.4.3.2 Argentina Obesity Intervention Devices Market
5.4.3.2.1 Argentina Obesity Intervention Devices Market by End User
5.4.3.2.2 Argentina Obesity Intervention Devices Market by Device
5.4.3.3 UAE Obesity Intervention Devices Market
5.4.3.3.1 UAE Obesity Intervention Devices Market by End User
5.4.3.3.2 UAE Obesity Intervention Devices Market by Device
5.4.3.4 Saudi Arabia Obesity Intervention Devices Market
5.4.3.4.1 Saudi Arabia Obesity Intervention Devices Market by End User
5.4.3.4.2 Saudi Arabia Obesity Intervention Devices Market by Device
5.4.3.5 South Africa Obesity Intervention Devices Market
5.4.3.5.1 South Africa Obesity Intervention Devices Market by End User
5.4.3.5.2 South Africa Obesity Intervention Devices Market by Device
5.4.3.6 Nigeria Obesity Intervention Devices Market
5.4.3.6.1 Nigeria Obesity Intervention Devices Market by End User
5.4.3.6.2 Nigeria Obesity Intervention Devices Market by Device
5.4.3.7 Rest of LAMEA Obesity Intervention Devices Market
5.4.3.7.1 Rest of LAMEA Obesity Intervention Devices Market by End User
5.4.3.7.2 Rest of LAMEA Obesity Intervention Devices Market by Device
Chapter 6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 Apollo Endosurgery, Inc. (Boston Scientific Corporation)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals and Trials:
6.3 ReShape Lifesciences, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research and Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.4 AbbVie, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.5 Allurion Technologies, Inc.
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Approvals and Trials:
6.5.2.2 Product Launches and Product Expansions:
6.6 Spatz FGIA, Inc.
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Approvals and trials:
6.7 Cousin Surgery
6.7.1 Company Overview
6.8 A.M.I. GmbH
6.8.1 Company Overview
6.9 ENDALIS
6.9.1 Company Overview
6.10. GI Dynamics, Inc.
6.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings